Back to search

Article

SGPL1 Deficiency Get Involved in Imatinib Resistance via PI 3 K-Akt signaling pathway in gastrointestinal stromal tumor

2025-05-28

Abstract excerpt

<title>Abstract</title> <p> Gastrointestinal stromal tumor (GIST) is the most common mesenchymal tumor in the gastrointestinal tract. In recent years, secondary resistance to the first-line drug imatinib has become its bottleneck of targeted therapy due to the unclear mechanism. It has important clinical significance for breaking through the bottleneck by screening and identifying the critical gene of imatinib r...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
ab1eb5e1-50e0-51c2-8990-9cb034ddb9ff
DOI
10.21203/rs.3.rs-6647302/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
SGPL1 Deficiency Get Involved in Imatinib Resistance via PI 3 K-Akt signaling pathway in gastrointestinal stromal tumorDOI 10.21203/rs.3.rs-6647302/v1
Select a neighboring publication to make it the new centre.